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ANIMAL GROWTH BIOTECHNOLOGY
IN A QUANDARY
ISSUE DIMENSIONS & OPTIONS
ABSTRACT
Agriculture has enjoyed dramatic successes through biotechnology in re-
cent decades and consumers have come to expect a bountiful, appealing, 
nutritious, healthful, economic, convenient and safe food supply. Con-
sumers now demand products which are desir-
able in composition and value, and safe and 
wholesome.
In order to meet these demands, several types 
of animal growth biotechnologies have been 
safely employed in food production systems for 
several decades and technologies now in several 
stages of development involve new types of 
growth regulators and recombinant ap-
proaches. While the “new” biotechnologies 
have been positioned as somehow different 
from those currently in use, attention and con-
cern in producer, consumer, political and activ-
ist arenas has arisen regarding both present and emerging growth regulat-
ing technologies, whether or not they involve recombinant technology. 
The European Economic Community (EEC) ban on anabolic growth 
regulators for economic and trade purposes under the guise of other is-
sues (i.e., safety) and moratoriums on the use of somatotropins for meat 
and milk production are examples of concerns and actions which have 
targeted animal growth technologies. Perceptions and facts are widely di-
vergent on these issues. Production of foods in systems untampered by 
humans surfaces as a common denominator in the discussions surround-
ing these issues.
To increase lean tissue and reduce fat deposition in animals, diet and 
health concerns along with animal efficiency in producing quality, safe, 
lean and healthful animal products all require immediate attention. The 
ability to produce highly palatable acceptable lean animal products is a
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critical priority for the animal industry. Consumer calorie-consciousness 
requires a sincere effort on the part of the animal products industry to 
produce leaner animal products.
All technology implemented in the production system must be concur-
rently marketed to the final consumer as well as producers; this is seldom 
accomplished. We can no longer use technologies which are inconsistent 
with consumers’ quality of life, and in the future, both the product as well 
as the systems used to produce it will need to be reflect consumers’ needs 
and attitudes.
This paper explores the current status of the issues surrounding animal 
growth technologies and identify options and strategies through which 
these technologies may be successfully advanced in concert with the inter-
ests and perceptions of the diverse parties affected by these issues. Discus-
sion papers on these issues were developed through a colloquia sponsored 
by the Texas A&M University Center for Biotechnology Policy and Ethics; 
these are excerpted below.
Some of the questions considered for discussion concerning animal growth 
regulating biotechnologies include:
—What are the implications in implementation or restriction of growth 
regulating technologies; will humans be better served?
—Why should these technologies be used? What are the benefits and who 
benefits?
—Who should be involved in the decisions and interchange involving use 
of these technologies for animals in food production? Should it involve 
those that do not use or consume foods produced with these products? 
—How can all dimensions of the issues surrounding decisions on use of 
these technologies be communicated?
—What patterns and strategies might be useful in developing new ap-
proaches to deal with the development and implementation of growth 
regulation technologies?
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INTRODUCTION
Understanding the issues surrounding animal growth biotechnologies re-
quires a look back at the issues that have developed, how they developed 
over time, the basis for the issues as well as how and why they are impor-
tant.
The target of animal industries is toward producing products that have 
a better consumer image and are aligned with consumer needs. For this 
discussion, the focus is on the use of biotechnology and other technolo-
gies to achieve these ends. The current aim is to produce what we call 
consumer-driven products—in composition and value—and systems 
which will be used to produce them. We are faced with the dilemma of 
choosing to use either traditional systems or biotechnology of some kind 
or a combination of both. Another question is, “Can we use them?” The 
concern of consumers is shifting from food itself to examining how it is 
produced.
Biotechnology might appear in food or it may be used to produce food. 
Consumers and other interested groups have certain expectations if we 
look at the growth area and animal products, most recently asking the 
question “Should biotechnology be used in food production?” and “Can 
we use biotechnology in a sustainable system or are we unable to develop 
an integrated system using biotechnology?”
The working group at Texas A&M studied some of the animal biotech-
nologies available and decided that certain technical issues, economic is-
sues and ethical issues associated with the specific technology and those 
associated with change resulting from technology use would be addressed. 
Some very important political ramifications need to be addressed as well 
as food safety implications, diet and health implications and the issue of 
perception vs reality.
Contributors to this paper included Drs. Martin Terry, Jeff Burkhardt, 
Cathy Lemieux, Dave Hutchinson and Gordon Carstens. Most contribu-
tors gave seminars which raised questions concerning biotechnology use 
and suggested some of the possible implications of its use. They also asked 
who should be involved in making decisions about technology use and ac-
ceptability, and what benefits would be accrued from biotechnology use. 
Excerpts from the seminar papers are included to discuss our findings.
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BACKGROUND PERSPECTIVES --- GROWTH REGULATION BIOTECHNOLOGIES
Floyd M. Byers, Animal Science, Texas A&M University
Our food production systems were developed under the premise of scar-
city. In developed countries where technology is used, innovation and 
technology have fostered an abundance of food and with it, a new set of 
societal values and expectations have emerged. The contemporary con-
sciousness concerning biotechnology and resource use in food production 
systems worldwide reflects the dramatic success of our food production 
systems which provide an abundance of food with little involvement on 
the part of most consumers. This independence from the drudgery of 
searching for food provides much of society with the opportunity to pur-
sue more fruitful endeavors toward advancement of humankind. A direct 
result of this dissociation is longer-term concern for the technology use 
in, and sustainability of, food production systems for future generations 
and maintaining and improving quality of life on the planet. Overriding 
issues concern application of biotechnology in food production, percep-
tions of resource use, and stewardship for resources planet-wide. Cer-
tainly, it was expected that different concerns would emerge when abun-
dance rather than scarcity of food becomes the norm. Animal growth 
regulation biotechnologies have contributed to the abundance of desired 
animal products in our food supply.
As a consequence, the entire social contract between consumers and ag-
riculture is now as never before in transition. The 1990s have become the 
decade of food safety and environmental awareness and consumers are 
demanding a safe, environmentally-sensitive and resource-conscious food 
supply and production system. Consumer-driven food products of desir-
able composition and value, that are assuredly safe and wholesome and 
that are produced in technologically, sociologically, and environmentally 
acceptable fashions are required. Consumers have an increasing interest in 
the diverse issues facing civilization, particularly those involving our food. 
How food is produced and the implications of biotechnology in food 
choices have surfaced as key issues about which the public now insists on 
being informed.
While science has responded with what is commonly described as an 
“information overload,” little of this reaches consumers in easily under-
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stood ten second sound bites, resulting in an information vacuum on is-
sues surrounding key aspects of food production. Since a vacuum will be 
filled, an ever expanding array of spokespersons representing key societal 
concerns and purportedly representing “consumers” are “carpet bomb-
ing” the communications media with targeted-simplified information 
(i.e., eat lower on the food chain, hormone-free, natural, etc.) to achieve 
specific and egalitarian objectives involving animal, cultural, environ-
mental and ethical dimensions of food production. In todays’ communi-
cation systems, perceptions gained through watching media messages us-
ing sounds, shapes and images take precedence over facts concerning food 
production issues, of which animal growth regulators are a component. In 
this forum, the credibility of the messenger has increasingly become a fo-
cus for discerning and forming perceptions and judgements on these is-
sues. It would certainly be unfortunate if safe, efficacious technologies for 
producing safer and healthier consumer-desirable animal products were 
rejected by, or unavailable to, consumers on the basis of misinformation, 
disinformation and perceptions. Unfortunately, the value of these tech-
nologies, in use and in development, was not or has not been communi-
cated to consumers with the same message penetration as the emotional 
appeal for “natural” food production systems, untampered by humans.
Current technologies used in animal (beef) production, for example 
(anabolic implants), modify (repartition) growth to allow production of 
leaner beef products with less fat. Similar technology does not yet exist in 
practice for other species. Emerging technologies, however, promise effec-
tive growth regulation options for beef, lamb, pork and poultry with pos-
sible applications for fish as well. Repartitioning of growth and conse-
quent modification of animal products has received major attention in re-
cent years, and clearly provides the most direct and efficacious mecha-
nism to change the protein and fat content of animal tissues. The objective 
is to modify the patterns of growth in animals to produce less fat in ani-
mals and more lean animal products. While this is the eventual target of 
genetic engineering initiatives, systems employing these concepts (i.e., 
transgenic animals) are not likely to surface in the marketplace soon. A 
number of options are feasible in developing systems employing growth 
regulating biotechnology in several forms to produce leaner animal prod-
ucts, and include estrogens, zeranol, androgens (i.e., TBA), growth hor-
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mone, beta agonists, immunization and growth hormone releasing factor. 
All of these options have been investigated to varying degrees across ani-
mal species in developing targeted growth management systems to most 
efficiently produce desired leaner animal products.
The mechanisms involved in redirection of growth include modifica-
tion of priorities for nutrient use for protein vs fat deposition, alteration 
of tissue turnover, modification of daily tissue deposition limits and 
modification of nutrient supply. Eventually, growth hormone, releasing 
factors for growth hormone, beta agonists and/or immunization strate-
gies to remove negative feedback on growth (i.e., somatostatin) may pro-
vide additional mechanisms with which to regulate growth. They may 
work in concert with or replace current growth regulation technology, 
and these alternatives are currently in development.
Currently used estrogenic growth regulators (i.e., beef cattle), like 
growth hormone and beta agonists in development for several animal spe-
cies, are effective repartitioning agents modifying growth by shifting nu-
trients from fat to protein accretion. Carcass animal products reflect accu-
mulative growth from birth to slaughter. As a consequence, use of growth 
regulation biotechnologies from birth to slaughter provides lifetime 
growth regulation and provides the maximal redirection of nutrients from 
fat to protein and lean tissue production. The longer growth regulators are 
provided, the greater is the increase in total animal product lean with a si-
multaneous reduction in fat. Across several recent studies, the percentage 
of carcass fat was reduced by - n percent with current anabolic repar-
titioning implants (zeranol, estradiol 176). Concurrent with this reduc-
tion in carcass fat, the percentage of lean retail product was increased by 
3.3 to 5.0 percent with these implant growth regulators. Reflecting the 
change in carcass composition and percentage retail product, the percent-
age of fat in the rib-eye muscle was reduced by 30 percent (from 3.8 to 2.6 
percent). Trim fat (subcutaneous) and internal fat were similarly reduced.
The use of current growth regulators thus results in beef products with 
less trim fat (which consumers may eat or leave as plate waste) and with 
substantially less fat in trimmed lean muscle (i.e., rib steak) food prod-
ucts. Concurrent with this reduction in fat, cholesterol delivered to con-
sumers will also be reduced, reflecting the two-fold higher cholesterol 
content of fat vs lean muscle. These growth regulation biotechnologies are
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therefore important components of integrated growth management sys-
tems to allow production of consumer-driven lean-diet health-desirable 
animal food products.
The growth regulators currently approved for use (for beef cattle) are 
either endogenous compounds already present in man and animals (es-
trogen, testosterone, progesterone) or are compounds developed through 
biotechnology to mimic these endogenous substances (zeranol, tren- 
bolone acetate). These growth regulators are currently used in over 95 per-
cent of all cattle on feed in the U.S. and in 50 to 75 percent of these same 
cattle during growth as calves and as stockers prior to feeding. None of 
these are ever fed to animals in the U.S.; they are instead placed in the ear, 
which does not normally enter the food chain. When used in cattle pro-
duction, residues in meat are extremely low and less than naturally occur-
ring levels in meat from cows and bulls. Levels of these substances (hor-
mones) produced in people every day are many thousands to millions 
times greater than present in meat either naturally or as a result of use of a 
growth regulator in cattle. Also, other foods, especially vegetables, salad 
oil, etc. provide thousands of times more estrogen than meat from cattle 
whether receiving growth regulators or not, and less than 10 percent of 
what is consumed is absorbed by humans, so the contribution from beef is 
truly negligible.
The EEC imposed a ban on import of beef from the U.S. and other 
countries using anabolic growth regulators commonly referred to as “hor-
mones.” While the ban was originally launched under the guise of a 
“safety” issue the directive for the ban has been adopted by the EEC al-
though all safety issues were dismissed long ago by both the EEC’s own 
commission “The Lamming Commission” and by the U.S. governments 
regulatory agencies (the Food Safety and Inspection Service (FSIS) branch 
of the Department of Agriculture (USDA) and by the Food and Drug Ad-
ministration (FDA)).
In contrast to the U.S., where biotechnology is tightly and efficiently 
regulated such that no violative residues were found in the past four years 
of USDA-FSIS’ National Residue Program, a fraction of meat produced in 
the EEC contains unacceptable residues of compounds never cleared for 
use, some of which are known carcinogens. A safety issue exists with EEC 
animal products because of unapproved “cocktails” of many potent drugs
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directly injected into the muscle of growing animals on EEC farms, as a 
result of the ban on use of approved products instated during the past 
several years.
Recent data were summarized to assess the impact on the U.S. industry. 
In a summary of growth regulation studies at Texas A&M, the change in 
net return on a lean retail product basis averaged $96.68 per animal. This 
represents a net value to the U.S. beef products industry of approximately 
$2.5 billion. These data are consistent with results of a recent USDA study 
indicating a $2.4 to $4.1 billion reduction in net return on a retail product 
basis if currently approved growth regulators were not used in the U.S., 
depending on feeding and marketing management alternatives. World-
wide implications would obviously be much greater and this is borne out 
in the USDA study.
Clearly, when safe, approved efficacious biotechnology is banned to 
serve popular, protectionist or political purposes, only unapproved tech-
nology will be available for use. Use of approved safe growth regulators al-
lows application of biotechnology to produce leaner animal products con-
sistent with diet health needs of consumers. The ban on this technology in 
the EEC has resulted in the delivery of fatter beef products to European 
consumers, a situation inconsistent with the needs of U.S. (and other) 
consumers. Similar restrictions are forthcoming or are currently in place 
regarding the use of growth hormone based technology currently in de-
velopment to modify meat animal products (i.e., EEC) or quantity of milk 
produced per animal (Minnesota, Wisconsin).
In producing environmentally sensitive animal products, the adoption 
of technology to reduce methane directly or growth regulators to enhance 
lean tissue growth reduce feed resources per unit of animal product and 
reduce the methane per unit of beef produced. Eliminating these tech-
nologies (i.e., growth regulation ban-EEC) results in a decrease in rates of 
lean tissue growth, more feed resources used and more methane per unit 
of beef or milk produced. Disallowing efficient meat production technol-
ogy (i.e., growth regulators ban-EEC) or as suggested for milk or meat 
production (i.e., BST ban-EEC) would have unwanted resource (feed, en-
ergy, water, etc.) and environmental implications.
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